{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:25:55Z","timestamp":1787610355159,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81901039"],"award-info":[{"award-number":["81901039"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This retrospective study investigated the clinicopathological characteristics of secretory carcinoma of salivary glands (SCSG) in 23 patients with histopathologically confirmed SCSG between January 2010 and December 2020. In total, 13 males and 10 females (ratio, 1.3:1) aged 10\u2009\u2212\u200969\u00a0years (median, 45\u00a0years) were enrolled in this study; the average disease duration was 2.44\u00a0years (0.25\u201320\u00a0years). Twenty-one patients (91.3%) had SCSG in the parotid gland, and two (8.7%) in the submandibular gland. All patients had single nodules of diameters 0.8\u20134.8\u00a0cm (average 2.6\u00a0cm); five with lymph node metastases, and two with distant metastases. Immunohistochemically, tumors stained positive for S-100, mammaglobin, CK7, GATA3 and pan-Trk, and negative for DOG1, P63, and calponin, with Ki-67 positivity from 1 to 50%.\n                    <jats:italic>ETV6<\/jats:italic>\n                    gene rearrangement was confirmed in 15 patients. All patients underwent oncological resection, four had radioactive particles implanted postoperatively, one received chemotherapy, and seven underwent chemoradiotherapy. Six patients had regional recurrences, two distant metastases, and one died before the last follow-up. SCSGs are typically indolent, with a low locoregional recurrence rate and excellent survival. Prognosis is correlated to clinical stage, pathological grade, and surgical procedures.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-01970-4","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T06:02:58Z","timestamp":1637560978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Clinicopathological characteristics and outcomes of 23 patients with secretory carcinoma of major salivary glands"],"prefix":"10.1038","volume":"11","author":[{"given":"Jingjing","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"1970_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","volume":"34","author":"A Sk\u00e1lov\u00e1","year":"2010","unstructured":"Sk\u00e1lov\u00e1, A. et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: A hitherto undescribed salivary gland tumor entity. Am. J. Surg. Pathol. 34, 599\u2013608. https:\/\/doi.org\/10.1097\/PAS.0b013e3181d9efcc (2010).","journal-title":"Am. J. Surg. Pathol."},{"key":"1970_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.bjoms.2016.07.029","volume":"55","author":"N Hindocha","year":"2017","unstructured":"Hindocha, N., Wilson, M. H., Pring, M., Hughes, C. W. & Thomas, S. J. Mammary analogue secretory carcinoma of the salivary glands: A diagnostic dilemma. Br. J. Oral Maxillofac. Surg. 55, 290\u2013292. https:\/\/doi.org\/10.1016\/j.bjoms.2016.07.029 (2017).","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"1970_CR3","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.4081\/rt.2017.7162","volume":"9","author":"O Bissinger","year":"2017","unstructured":"Bissinger, O. et al. Mammary analogue secretory carcinoma of salivary glands: Diagnostic pitfall with distinct immunohistochemical profile and molecular features. Rare Tumors 9, 7162. https:\/\/doi.org\/10.4081\/rt.2017.7162 (2017).","journal-title":"Rare Tumors"},{"key":"1970_CR4","doi-asserted-by":"publisher","first-page":"1497023","DOI":"10.1155\/2017\/1497023","volume":"2017","author":"R Naous","year":"2017","unstructured":"Naous, R., Zhang, S., Valente, A., Stemmer, M. & Khurana, K. K. Utility of immunohistochemistry and Etv6 (12p13) gene rearrangement in identifying secretory carcinoma of salivary gland among previously diagnosed cases of acinic cell carcinoma. Pathol. Res. Int. 2017, 1497023. https:\/\/doi.org\/10.1155\/2017\/1497023 (2017).","journal-title":"Pathol. Res. Int."},{"key":"1970_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00795-020-00256-4","volume":"54","author":"Y Hamamoto","year":"2021","unstructured":"Hamamoto, Y. et al. Usefulness of immunohistochemistry to distinguish between secretory carcinoma and acinic cell carcinoma in the salivary gland. Med. Mol. Morphol. 54, 23\u201330. https:\/\/doi.org\/10.1007\/s00795-020-00256-4 (2021).","journal-title":"Med. Mol. Morphol."},{"key":"1970_CR6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.6004\/jnccn.2020.0031","volume":"18","author":"DG Pfister","year":"2020","unstructured":"Pfister, D. G. et al. Head and neck cancers, version 2.2020. J. Natl. Compr. Cancer. Netw. 18, 873\u2013898. https:\/\/doi.org\/10.6004\/jnccn.2020.0031 (2020).","journal-title":"J. Natl. Compr. Cancer. Netw."},{"key":"1970_CR7","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.21.00449","volume":"39","author":"JL Geiger","year":"2021","unstructured":"Geiger, J. L. et al. Management of salivary gland malignancy: ASCO guideline. J. Clin. Oncol. 39, 1909\u20131941. https:\/\/doi.org\/10.1200\/JCO.21.00449 (2021).","journal-title":"J. Clin. Oncol."},{"key":"1970_CR8","doi-asserted-by":"publisher","first-page":"30161","DOI":"10.1016\/j.oooo.2020.04.007","volume":"S2212\u20134403","author":"LDB Alves","year":"2020","unstructured":"Alves, L. D. B. et al. A systematic review of secretory carcinoma of the salivary gland: Where are we?. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. S2212\u20134403, 30161\u201330169. https:\/\/doi.org\/10.1016\/j.oooo.2020.04.007 (2020).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"1970_CR9","doi-asserted-by":"publisher","first-page":"997","DOI":"10.5858\/arpa.2015-0075-RS","volume":"140","author":"V Parekh","year":"2016","unstructured":"Parekh, V. & Stevens, T. M. Mammary analogue secretory carcinoma. Arch. Pathol. Lab. Med. 140, 997\u20131001. https:\/\/doi.org\/10.5858\/arpa.2015-0075-RS (2016).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"1970_CR10","doi-asserted-by":"publisher","first-page":"203636132110091","DOI":"10.1177\/20363613211009144","volume":"13","author":"J Burlile","year":"2021","unstructured":"Burlile, J. et al. A case of metachronous bilateral secretory carcinoma. Rare Tumors 13, 20363613211009144. https:\/\/doi.org\/10.1177\/20363613211009144 (2021).","journal-title":"Rare Tumors"},{"key":"1970_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/PAT.0000000000000179","volume":"46","author":"IM Zardawi","year":"2014","unstructured":"Zardawi, I. M. & Hook, P. Mammary analogue secretory carcinoma of minor salivary glands. Pathology 46, 667\u2013669. https:\/\/doi.org\/10.1097\/PAT.0000000000000179 (2014).","journal-title":"Pathology"},{"key":"1970_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.prp.2012.12.005","volume":"114","author":"FJ Kratochvil","year":"2012","unstructured":"Kratochvil, F. J., Stewart, J. C. & Moore, S. R. Mammary analog secretory carcinoma of salivary glands: A report of 2 cases in the lips. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 114, 630\u2013635. https:\/\/doi.org\/10.1016\/j.prp.2012.12.005 (2012).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"1970_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ajoms.2020.08.009","volume":"33","author":"H Takano","year":"2020","unstructured":"Takano, H. et al. A case of secretory carcinoma of the minor salivary gland in the buccal mucosa. J. Oral Maxillofac. Surg. Med. Pathol. 33, 136\u2013140. https:\/\/doi.org\/10.1016\/j.ajoms.2020.08.009 (2020).","journal-title":"J. Oral Maxillofac. Surg. Med. Pathol."},{"key":"1970_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.oraloncology.2018.04.022","volume":"82","author":"E Boon","year":"2018","unstructured":"Boon, E. et al. Clinicopathological characteristics and outcome of 31 patients with Etv6-Ntrk3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands. Oral Oncol. 82, 29\u201333. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.04.022 (2018).","journal-title":"Oral Oncol."},{"key":"1970_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.21147\/j.issn.1000-9604.2017.05.01","volume":"29","author":"I Ryoko","year":"2017","unstructured":"Ryoko, I. et al. Secretory carcinoma\u2014Impact of translocation and gene fusions on salivary gland tumor. Chin. J. Cancer Res. 29, 379\u2013384. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2017.05.01 (2017).","journal-title":"Chin. J. Cancer Res."},{"key":"1970_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12105-017-0784-3","volume":"11","author":"J Guilmette","year":"2017","unstructured":"Guilmette, J. et al. Ultrastructural characterization of mammary analogue secretory carcinoma of the salivary glands: A distinct entity from acinic cell carcinoma?. Head Neck Pathol. 11, 419\u2013426. https:\/\/doi.org\/10.1007\/s12105-017-0784-3 (2017).","journal-title":"Head Neck Pathol."},{"key":"1970_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1034\/j.1601-0825.2002.02870.x","volume":"8","author":"PM Speight","year":"2002","unstructured":"Speight, P. M. & Barrett, A. W. Salivary gland tumours. Oral Dis. 8, 229\u2013240. https:\/\/doi.org\/10.1034\/j.1601-0825.2002.02870.x (2002).","journal-title":"Oral Dis."},{"key":"1970_CR18","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s12105-018-0935-1","volume":"13","author":"C Mossinelli","year":"2018","unstructured":"Mossinelli, C. et al. Synchronous parotid (mammary analog) secretory carcinoma and acinic cell carcinoma: Report of a case. Head Neck Pathol. 13, 686\u2013691. https:\/\/doi.org\/10.1007\/s12105-018-0935-1 (2018).","journal-title":"Head Neck Pathol."},{"key":"1970_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/jop.12226","volume":"44","author":"F Projetti","year":"2015","unstructured":"Projetti, F. et al. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: Usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?. J. Oral Pathol. Med. 44, 244\u2013251. https:\/\/doi.org\/10.1111\/jop.12226 (2015).","journal-title":"J. Oral Pathol. Med."},{"key":"1970_CR20","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/modpathol.2017.32","volume":"30","author":"G Krings","year":"2017","unstructured":"Krings, G. et al. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas. Mod. Pathol. 30, 1086\u20131099. https:\/\/doi.org\/10.1038\/modpathol.2017.32 (2017).","journal-title":"Mod. Pathol."},{"key":"1970_CR21","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/hed.24755","volume":"39","author":"BA Khalele","year":"2017","unstructured":"Khalele, B. A. Systematic review of mammary analog secretory carcinoma of salivary glands at seven years after description. Head Neck 39, 1243\u20131248. https:\/\/doi.org\/10.1002\/hed.24755 (2017).","journal-title":"Head Neck"},{"key":"1970_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00428-011-1098-6","volume":"459","author":"C Griffith","year":"2011","unstructured":"Griffith, C., Seethala, R. & Chiosea, S. I. Mammary analogue secretory carcinoma: A new twist to the diagnostic dilemma of zymogen granule poor acinic cell carcinoma. Virchows Arch. 459, 117\u2013118. https:\/\/doi.org\/10.1007\/s00428-011-1098-6 (2011).","journal-title":"Virchows Arch."},{"key":"1970_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00428-014-1701-8","volume":"466","author":"H Majewska","year":"2015","unstructured":"Majewska, H. et al. Mammary analogue secretory carcinoma of salivary glands: A new entity associated with ETV6 gene rearrangement. Virchows Arch. 466, 245\u2013254. https:\/\/doi.org\/10.1007\/s00428-014-1701-8 (2015).","journal-title":"Virchows Arch."},{"key":"1970_CR24","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.prp.2017.07.017","volume":"213","author":"F Baghai","year":"2017","unstructured":"Baghai, F., Yazdani, F., Etebarian, A., Garajei, A. & Skalova, A. Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin. Pathol. Res. Pract. 213, 1112\u20131118. https:\/\/doi.org\/10.1016\/j.prp.2017.07.017 (2017).","journal-title":"Pathol. Res. Pract."},{"key":"1970_CR25","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/annonc\/mdw042","volume":"27","author":"A Drilon","year":"2016","unstructured":"Drilon, A. et al. What hides behind the MASC: Clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC). Ann. Oncol. 27, 920\u2013926. https:\/\/doi.org\/10.1093\/annonc\/mdw042 (2016).","journal-title":"Ann. Oncol."},{"key":"1970_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/his.13981","volume":"76","author":"X Bin","year":"2020","unstructured":"Bin, X. et al. Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool in diagnosing secretory carcinoma of salivary gland and detecting ETV6-NTRK3 fusion. Histopathology 76, 375\u2013382. https:\/\/doi.org\/10.1111\/his.13981 (2020).","journal-title":"Histopathology"},{"key":"1970_CR27","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s12105-019-01074-6","volume":"14","author":"M Black","year":"2020","unstructured":"Black, M. et al. Concurrent identification of novel Egfr-Sept14 fusion and Etv6-Ret fusion in secretory carcinoma of the salivary gland. Head Neck Pathol. 14, 817\u2013821. https:\/\/doi.org\/10.1007\/s12105-019-01074-6 (2020).","journal-title":"Head Neck Pathol."},{"key":"1970_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/his.13981","volume":"76","author":"B Xu","year":"2020","unstructured":"Xu, B. et al. Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting Etv6-Ntrk3 fusion. Histopathology 76, 375\u2013382. https:\/\/doi.org\/10.1111\/his.13981 (2020).","journal-title":"Histopathology"},{"key":"1970_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/PAS.0000000000000088","volume":"38","author":"A Sk\u00e1lov\u00e1","year":"2014","unstructured":"Sk\u00e1lov\u00e1, A. et al. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: Report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, \u03b2-catenin, EGFR, and CCND1 genes. Am. J. Surg. Pathol. 38, 23\u201333. https:\/\/doi.org\/10.1097\/PAS.0000000000000088 (2014).","journal-title":"Am. J. Surg. Pathol."},{"key":"1970_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijscr.2019.01.004","volume":"55","author":"L Sun","year":"2019","unstructured":"Sun, L. et al. A case report of parotid mammary analogue secretory carcinoma and reviews. Int. J. Surg. Case Rep. 55, 88\u201391. https:\/\/doi.org\/10.1016\/j.ijscr.2019.01.004 (2019).","journal-title":"Int. J. Surg. Case Rep."},{"key":"1970_CR31","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ijom.2019.01.027","volume":"48","author":"N Tokuzen","year":"2019","unstructured":"Tokuzen, N., Goda, H. & Nakashiro, K. Locally advanced mammary analogue secretory carcinoma of the parotid gland. Int. J. Oral Maxillofac. Surg. 48, 865\u2013868. https:\/\/doi.org\/10.1016\/j.ijom.2019.01.027 (2019).","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"1970_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","volume":"21","author":"SH David","year":"2020","unstructured":"David, S. H. et al. Larotrectinib in patients with TRK fusion-positive solid tumours: A pooled analysis of three phase 1\/2 clinical trials. Lancet Oncol. 21, 531\u2013540. https:\/\/doi.org\/10.1016\/S1470-2045(19)30856-3 (2020).","journal-title":"Lancet Oncol."},{"key":"1970_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","volume":"21","author":"CD Robert","year":"2020","unstructured":"Robert, C. D. et al. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: Integrated analysis of three phase 1\u20132 trials. Lancet Oncol. 21, 271\u2013282. https:\/\/doi.org\/10.1016\/S1470-2045(19)30691-6 (2020).","journal-title":"Lancet Oncol."},{"key":"1970_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bjoms.2019.11.003","volume":"58","author":"DH Lee","year":"2020","unstructured":"Lee, D. H., Kim, J. H., Yoon, T. M., Lee, J. K. & Lim, S. C. Outcomes of treatment of mammary analogue secretory carcinoma of the parotid gland. Br. J. Oral Maxillofac. Surg. 58, 158\u2013162. https:\/\/doi.org\/10.1016\/j.bjoms.2019.11.003 (2020).","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"1970_CR35","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12105-013-0443-2","volume":"7","author":"L Williams","year":"2013","unstructured":"Williams, L. & Chiosea, S. I. Mammary analogue secretory carcinoma mimicking salivary adenoma. Head Neck Pathol. 7, 316\u2013319. https:\/\/doi.org\/10.1007\/s12105-013-0443-2 (2013).","journal-title":"Head Neck Pathol."},{"key":"1970_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/PAS.0b013e318242a5b0","volume":"36","author":"SI Chiosea","year":"2012","unstructured":"Chiosea, S. I., Griffith, C., Assaad, A. & Seethala, R. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am. J. Surg. Pathol. 36, 343\u2013350. https:\/\/doi.org\/10.1097\/PAS.0b013e318242a5b0 (2012).","journal-title":"Am. J. Surg. Pathol."},{"key":"1970_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fsurg.2018.00039","volume":"5","author":"T Jovanna","year":"2018","unstructured":"Jovanna, T. et al. Contemporary management of benign and malignant parotid tumors. Front. Surg. 5, 39. https:\/\/doi.org\/10.3389\/fsurg.2018.00039 (2018).","journal-title":"Front. Surg."},{"key":"1970_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7416302","author":"C Boliere","year":"2019","unstructured":"Boliere, C., Murphy, J., Qaisi, M., Manosca, F. & Fung, H. Mammary analogue secretory carcinoma of the palate: Case report and review of the literature. Case Rep. Dent. https:\/\/doi.org\/10.1155\/2019\/7416302 (2019).","journal-title":"Case Rep. Dent."},{"key":"1970_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1200\/JCO.18.00573","volume":"37","author":"CM Albert","year":"2019","unstructured":"Albert, C. M., Davis, J. L., Federman, N., Casanova, M. & Laetsch, T. W. TRK fusion cancers in children: A clinical review and recommendations for screening. J. Clin. Oncol. 37, 513\u2013524. https:\/\/doi.org\/10.1200\/JCO.18.00573 (2019).","journal-title":"J. Clin. Oncol."},{"key":"1970_CR40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/pin.13100","volume":"71","author":"A Satsuki","year":"2021","unstructured":"Satsuki, A. et al. High-grade salivary gland carcinoma with the ETV6-NTRK3 gene fusion: A case report and literature review of secretory carcinoma with high-grade transformation. Pathol. Int. 71, 427\u2013434. https:\/\/doi.org\/10.1111\/pin.13100 (2021).","journal-title":"Pathol. Int."},{"key":"1970_CR41","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/1066896917709350","volume":"25","author":"NA Cipriani","year":"2017","unstructured":"Cipriani, N. A. et al. Salivary gland secretory carcinoma with high-grade transformation, Cdkn2a\/B loss, distant metastasis, and lack of sustained response to crizotinib. Int. J. Surg. Pathol. 25, 613\u2013618. https:\/\/doi.org\/10.1177\/1066896917709350 (2017).","journal-title":"Int. J. Surg. Pathol."},{"key":"1970_CR42","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.joms.2019.01.002","volume":"77","author":"JJ Sun","year":"2019","unstructured":"Sun, J. J. et al. Higher Ki67 index, nodal involvement, and invasive growth were high risk factors for worse prognosis in conventional mammary analogue secretory carcinoma. J. Oral Maxillofac. Surg. 77, 1187\u20131202. https:\/\/doi.org\/10.1016\/j.joms.2019.01.002 (2019).","journal-title":"J. Oral Maxillofac. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01970-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01970-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01970-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T12:29:41Z","timestamp":1670070581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01970-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-01970-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-249091\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-249091\/v2","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]},"assertion":[{"value":"2 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22639"}}